Cargando…
Locally advanced rectal cancer: management challenges
Between 5% and 10% of patients with rectal cancer present with locally advanced rectal cancer (LARC), and 10% of rectal cancers recur after surgery, of which half are limited to locoregional disease only (locally recurrent rectal cancer). Exenterative surgery offers the best long-term outcomes for p...
Autores principales: | Kokelaar, RF, Evans, MD, Davies, M, Harris, DA, Beynon, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066998/ https://www.ncbi.nlm.nih.gov/pubmed/27785074 http://dx.doi.org/10.2147/OTT.S100806 |
Ejemplares similares
-
Meta-analysis of the prognostic value of CpG island methylator phenotype in rectal cancer
por: Kokelaar, R. F., et al.
Publicado: (2018) -
Selection Criteria for the Radical Treatment of Locally Advanced Rectal Cancer
por: Davies, Mansel Leigh, et al.
Publicado: (2011) -
Advances in the treatment of locally advanced rectal cancer
por: Ali, Fadwa, et al.
Publicado: (2020) -
Challenges and shifting treatment strategies in the surgical treatment of locally advanced rectal cancer
por: Kim, Ho Seung, et al.
Publicado: (2020) -
Novelties in treatment of locally advanced rectal cancer
por: Grass, Fabian, et al.
Publicado: (2018)